Tilray's Marijuana Rescheduling News Fails to Sustain Market Gains
Tilray Brands (TLRY) and other marijuana stocks experienced a brief surge following news of the U.S. Department of Justice rescheduling regulated marijuana, but quickly lost those gains. The rescheduling from Schedule I to Schedule III does not immediately open the U.S. market for cannabis companies, leading to a quick reversal in investor sentiment.
Tickers: $TLRY
Topics: marijuana stocks rescheduling news stock price movement Tilray Brands